GlaxoSmithKline and Medicago Team Up to Develop COVID-19 Vaccine

GSK, Medicago Forge Agreement to Develop Novel Adjuvanted COVID-19 Vaccine based on Medicago's Virus-Like Particle (VLP) technology $GSK $MRNA $JNJ $AZN #vaccine #stockmarket #investment https://t.co/BGbqM3Oqph